Becton, Dickinson and Company BDX

Medical - Instruments & Supplies, Healthcare

$180.16

−0.08%

Market cap: $49.1B
PE: 54.3×; 10y median 47.3×
Forward PE
Price to sales: 2.4×
EV/EBIT: 17.8×
Revenue, 12 months: $20.8B; −3% on a year ago
Net margin: 4.5%
Free cash flow yield: 6.5%

Becton, Dickinson and trades at 54.3× trailing earnings, pricier than 65% of the last ten years. Revenue was $20.8B over the last twelve months, down 3% on a year earlier with a 5% net margin.

Charts

Financials

Income statement for BDX, by quarter
Income statement	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26
	$4.7B	$5B	$5B	$5.4B	$5.2B+10%	$5.3B+5%	$5.5B+10%	$5.9B+8%	$5.3B+2%	$4.7B−11%	$5B−10%
Cost of revenue	$2.7B	$2.7B	$2.7B	$3B	$2.9B+10%	$3B+10%	$2.9B+7%	$3.1B+5%	$2.8B−3%	$2.6B−15%	$2.7B−7%
Gross profit	$2B	$2.3B	$2.3B	$2.5B	$2.2B+10%	$1.9B−19%	$2.2B−3%	$4B+62%	$2.4B+8%	$2.2B+16%	$2.3B+4%
R&D	$290M	$299M	$299M	$302M	$343M+18%	$302M+1%	$297M−1%	$322M+7%	$306M−11%	$249M−18%	$258M−13%
SG&A	$1.2B	$1.2B	$1.2B	$1.3B	$1.3B+9%	$1.3B+7%	$1.3B+10%	$1.4B+9%	$1.4B+6%	$1.2B−5%	$1.3B−5%
	$439M	$734M	$602M	$622M	$453M+3%	$546M−26%	$739M+23%	$1.2B+89%	$552M+22%	$93M−83%	$663M−10%
Interest expense	$111M	$125M	$137M	$155M	$155M+40%	$151M+21%	$152M+11%	$155M+0%	$107M−31%	$149M−1%	$132M−13%
Pre-tax income	$359M	$633M	$500M	$514M	$306M−15%	$363M−43%	$569M+14%	$975M+90%	$393M+28%	$39M−89%	$554M−3%
	$77M	$96M	$13M	$114M	$3M−96%	$55M−43%	$118M+808%	$52M−54%	$11M+267%	$76M+38%	$102M−14%
Net income	$281M	$537M	$487M	$400M	$303M+8%	$308M−43%	$574M+18%	$493M+23%	$382M+26%	−$311M	$377M−34%
	$0.96	$1.85	$1.68	$1.45	$1.04+8%	$1.07−42%	$2.00+19%	$1.72+19%	$1.34+29%	−$1.11	$1.37−32%
	291.4M	290.3M	290.3M	290.6M	290.4M−0%	289.2M−0%	288.7M−1%	287.1M−1%	285.1M−2%	280.6M−3%	275.2M−5%

From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.

Estimates

Next earnings report: Nov 5, 2026.

Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.

Peers

Companies in Medical - Instruments & Supplies within ten times Becton, Dickinson and's size, closest in size first.

Company	Market cap	PE	Its 10y median PE	P/S	Revenue growth	Net margin
BDXBecton, Dickinson and Company	$49.1B	54.3×	47.3×	2.4×	−3%	4.5%
MDLNMedline Inc.	$46.6B	41.2×	32.3×	1.6×	+15%	—
RMDResMed Inc.	$32.6B	21.7×	37.3×	5.8×	+10%	26.9%
WSTWest Pharmaceutical Services, Inc.	$25.8B	46.9×	45.8×	7.8×	+12%	17.0%
ISRGIntuitive Surgical, Inc.	$146.4B	47.5×	69.0×	13.3×	+21%	28.4%
Peer median	$39.6B	44.1×	41.5×	6.8×	+14%	26.9%

About

Industry: Medical - Instruments & Supplies
Sector: Healthcare

Valuation data, not investment advice. Prices as of Oct 7, 2026.

Income statement

$4.7B

$5B

$5.4B

$5.2B+10%

$5.3B+5%

$5.5B+10%

$5.9B+8%

$5.3B+2%

$4.7B−11%

$5B−10%

Cost of revenue

$2.7B

$3B

$2.9B+10%

$3B+10%

$2.9B+7%

$3.1B+5%

$2.8B−3%

$2.6B−15%

$2.7B−7%

Gross profit

$2B

$2.3B

$2.5B

$2.2B+10%

$1.9B−19%

$2.2B−3%

$4B+62%

$2.4B+8%

$2.2B+16%

$2.3B+4%

R&D

$290M

$299M

$302M

$343M+18%

$302M+1%

$297M−1%

$322M+7%

$306M−11%

$249M−18%

$258M−13%

SG&A

$1.2B

$1.3B

$1.3B+9%

$1.3B+7%

$1.3B+10%

$1.4B+9%

$1.4B+6%

$1.2B−5%

$1.3B−5%

$439M

$734M

$602M

$622M

$453M+3%

$546M−26%

$739M+23%

$1.2B+89%

$552M+22%

$93M−83%

$663M−10%

Interest expense

$111M

$125M

$137M

$155M

$155M+40%

$151M+21%

$152M+11%

$155M+0%

$107M−31%

$149M−1%

$132M−13%

Pre-tax income

$359M

$633M

$500M

$514M

$306M−15%

$363M−43%

$569M+14%

$975M+90%

$393M+28%

$39M−89%

$554M−3%

$77M

$96M

$13M

$114M

$3M−96%

$55M−43%

$118M+808%

$52M−54%

$11M+267%

$76M+38%

$102M−14%

Net income

$281M

$537M

$487M

$400M

$303M+8%

$308M−43%

$574M+18%

$493M+23%

$382M+26%

−$311M

$377M−34%

$0.96

$1.85

$1.68

$1.45

$1.04+8%

$1.07−42%

$2.00+19%

$1.72+19%

$1.34+29%

−$1.11

$1.37−32%

291.4M

290.3M

290.6M

290.4M−0%

289.2M−0%

288.7M−1%

287.1M−1%

285.1M−2%

280.6M−3%

275.2M−5%

Company

Market cap

Its 10y median PE

Fwd PE

P/S

Revenue growth

Net margin

BDXBecton, Dickinson and Company

$49.1B

54.3×

47.3×

2.4×

−3%

4.5%

MDLNMedline Inc.

$46.6B

41.2×

32.3×

1.6×

+15%

—

RMDResMed Inc.

$32.6B

21.7×

37.3×

5.8×

+10%

26.9%

WSTWest Pharmaceutical Services, Inc.

$25.8B

46.9×

45.8×

7.8×

+12%

17.0%

ISRGIntuitive Surgical, Inc.

$146.4B

47.5×

69.0×

13.3×

+21%

28.4%

Peer median

$39.6B

44.1×

41.5×

6.8×

+14%

26.9%